Clinical Trials

Inclusion Criteria:

• Hospitalized patients who are indicated for a screening, diagnostic, surveillance or therapeutic colonoscopy.
• Patients' age > 22 years.
• Patient has signed the informed consent.

Exclusion Criteria:

• Patients with known Inflammatory Bowel Disease and / or active Colitis.
• Patients with active diverticulitis.
• Patients with known or detected (during colonoscopy) bowel obstruction.
• Patients with BMI ≤ 18 .
• Patients with ascites Child Pugh C.
• Patients who are 30 days post-transplant.
• Patients treated with Peritoneal dialysis.
• Patients under active IV inotropic medications.
• Patients with LVAD.
• Patients who have active anticoagulant medications (excluding aspirin) or dual antiplatelet therapy in their system prior to the procedure. (Note: to avoid exclusion therapy should be discontinued 48 hours or greater prior to the procedure based on discretion of physician).
• Subjects with known coagulation disorder (INR ≥ 2 or platelets <50,000).
• Subjects with hemodynamic instability.
• Pregnancy (as stated by patient) or breast feeding.
• Subjects with altered mental status/inability to provide informed consenPatients who have participated in another interventional clinical study in the last 2 months.